SGSandra Elisa Adami Batista Gonçalves

Sandra Elisa Adami Batista Gonçalves

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sandra Elisa Adami Batista Gonçalves has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Hypoglycemia post bariatric surgery: drugs with different mechanisms of action to treat a unique disorder

    by Giovanna Braganholo Carpentieri, Sandra Elisa Adami Batista Gonçalves, Walid Mohamed Mourad, Lara Guimarães Carelo Pinto, Maria Teresa Zanella

    Postprandial hypoglycemia (PPH) is a complex and multifactorial complication of bariatric surgery (BS). PPH may cause severe symptoms or be asymptomatic. The treatment of this condition requires dietary changes, but severe cases require drug therapy. The number of therapeutic options is limited and are often associated with adverse side effects. Different classes of drugs have been used and tested, but the resolution of PPH remains a challenge for physicians and patients. In this review, we gathered articles on PPH [...] ABSTRACT Postprandial hypoglycemia (PPH) is a complex and multifactorial complication of bariatric surgery (BS). PPH may cause severe symptoms or be asymptomatic. The treatment of this condition requires dietary changes, but severe cases require drug therapy. The number of therapeutic options is limited and are often associated with adverse side effects. Different classes of drugs have been used and tested, but the resolution of PPH remains a challenge for physicians and patients. In this review, we gathered articles on PPH


  • SGLT2 Inhibition with Empagliflozin as a Possible Therapeutic Option for Postprandial Hypoglycemia After Bariatric Surgery

    by Giovanna B. Carpentieri, Sandra E. A. B. Gonçalves, Mayra Z. Casagrande, Walid M. Mourad, Lara G. C. Pinto, Maria Teresa Zanella

    Purpose Since SGLT2 inhibitors may reduce postprandial hyperglycemia, this study aimed to evaluated whether empagliflozin might be useful in the treatment of postprandial hypoglycemia (PPH) postbariatric surgery (BS). Patients and Methods Fourteen patients who underwent BS, nine without type 2 diabetes and five with diabetes before surgery and in remission after surgery, were included. Seven of them presented symptoms of PPH (hypoglycemic group; HG) and seven were asymptomatic (nonhypoglycemic group (NHG)). A meal tolerance test was performed before and after administration of a daily dose of empagliflozin (EMPA) 25 mg for 3 days. Plasma glucose and serum insulin levels were measured. Results In HG, compared with NHG, in the basal test, the area under the curve (AUC) of plasma glucose levels (AUCgly) was smaller (158.3 ± 25.3 vs 276.6 ± 79.2 mg h dL−1; p = 0.001) while the AUC of insulin levels (AUCins) did not differ, leading to a higher AUCins/AUCgly ratio (0.79 ± 0.46 vs 0.38 ± 0.20; p = 0.055) and a lower HOMA-IR (0.92 ± 0.22 vs 1.75 ± 0.77; p = 0.030). The HG after EMPA, but not the NHG, showed significant increases in glycemia leading to greater AUCgly (158.0 ± 25.3 to 197.2 ± 51.6 mg h dL−1; p = 0.043) without significant changes in AUCins. HOMA-IR increased only in the HG (0.92 ± 0.20 vs 1.61 ± 0.30; p = 0.025) and, when both groups were analyzed together, both before and post EMPA, a significant correlation was found between HOMA-IR and AUCgly values (r = 0.594; p = 0.002). Conclusion Our results suggest that empagliflozin increased glycemic levels in patients with PPH possibly through increases in hepatic glucose production. Graphical abstract


  • Association between thiamine deficiency and hyperlactatemia among critically ill patients with diabetes infected by SARS‐CoV‐2

    by Sandra Elisa Adami Batista Gonçalves, Thiago José Martins Gonçalves, Andreia Guarnieri, Rodrigo Cristovão Risegato, Maysa Penteado Guimarães, Daniella Cabral de Freitas

    Background: The present study aims to verify the association between diabetes and thiamine deficiency in critically ill patients infected by severe acute respiratory syndrome coronavirus 2.Methods: This is a descriptive cross‐sectional study, whose demographic, anthropometric, and laboratory data (arterial lactate, bicarbonate, and plasma thiamine) were obtained in the first hours of admission to the intensive care unit. Patients with diabetes were compared with individuals without diabetes, and the correlation was performed between thiamine and lactate levels. Thiamine levels P < .001). There was a strong negative correlation between thiamine and arterial lactate in patients with diabetes (r = −0.711, P < .001) and a moderate negative correlation in critically ill patients without diabetes (r = −0.489, P < .001).Conclusions: The prevalence of thiamine deficiency in critically ill patients due to coronavirus disease 2019 is higher in patients with diabetes. There is a negative correlation between thiamine and arterial lactate levels, which is higher in people with diabetes.


  • Open Access

    Challenging and Practical Aspects of Nutrition in Chronic Graft-versus-Host Disease

    by Andrea Z. Pereira, Sandra Elisa Adami Gonçalves, Morgani Rodrigues, Nelson Hamerschlak, Mary E. Flowers


  • Open Access

    Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: Elderly

    by Sandra Elisa Adami Batista Gonçalves, Andreza Alice Feitosa Ribeiro, Erika Yuri Hirose, Fabio Pires de Souza Santos, Flávia Munhoz Ferreira, Ludmila de Oliveira Muniz Koch, Márcia Tanaka, Mayara Santos de Souza, Polianna Mara Rodrigues Souza, Thiago Jose Martins Gonçalves, et al.

    The Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: Elderly was elaborated by nutritionists, nutrologists and hematologists physicians from 15 Brazilians reference centers in hematopoietic stem cell transplantation, in order to emphasize the importancy of nutritional status and the body composition during the treatment, as well as the main characteristics related to patient's nutritional assessment. Establishing the consensus, we intended to improve and standardize the nutritional therapy during the hematopoietic stem cell transplantation. The Consensus was approved by the Brazilian Society of Bone Marrow Transplantation.